Search research articles
Contact Us
Filters
Showing results (1-10 of 1,525) with videos related to
Page
of 153
Sort By:
The Lancet. Diabetes & Endocrinology
|
February 13, 2016
PCSK9 inhibition in type 2 diabetes: so far so good, but not there yet
Raul D Santos
European Heart Journal. Cardiovascular Pharmacotherapy
|
October 9, 2018
Beware of early drug intolerance in secondary prevention of cardiovascular disease
Raul D Santos
The Journal of Clinical Endocrinology and Metabolism
|
December 18, 2023
Elevated Lipoprotein(a) and Its Implications for Familial Hypercholesterolemia Diagnosis, Prognosis, and Family Screening
Raul D Santos
Atherosclerosis
|
June 23, 2009
Commentary on the study of Rivera et al.: The relation of risk factors and total coronary artery plaque burden evaluated by multi-detector row computed tomography angiography
Raul D Santos
Endocrine
|
March 28, 2012
Elevated uric acid, the metabolic syndrome and cardiovascular disease: cause, consequence, or just a not so innocent bystander?
Raul D Santos
Boletin Medico Del Hospital Infantil De Mexico
|
August 1, 1988
[Growth in children receiving a renal transplant]
D Santos-Atherton
Atherosclerosis
|
January 16, 2020
Absence of coronary artery calcification and low rates not only of coronary and cardiovascular mortality: Can the power of zero be expanded beyond the vessels?
Raul D Santos
Journal of Clinical Lipidology
|
September 19, 2020
From the President of the International Atherosclerosis Society
Raul D Santos
European Journal of Preventive Cardiology
|
February 21, 2021
EUROASPIRE V and uncontrolled risk factors in primary prevention: Atherosclerotic cardiovascular disease in the making
Raul D Santos
European Journal of Preventive Cardiology
|
February 21, 2019
Inadequate control of atherosclerotic cardiovascular disease risk factors in Europe: EUROASPIRE repeats itself
Raul D Santos
Page
of 153
Search research articles
Search
Showing results (1-10 of 1,525) with videos related to
Sort By:
Page
of 153
The Lancet. Diabetes & Endocrinology
|
February 13, 2016
PCSK9 inhibition in type 2 diabetes: so far so good, but not there yet
Raul D Santos
European Heart Journal. Cardiovascular Pharmacotherapy
|
October 9, 2018
Beware of early drug intolerance in secondary prevention of cardiovascular disease
Raul D Santos
The Journal of Clinical Endocrinology and Metabolism
|
December 18, 2023
Elevated Lipoprotein(a) and Its Implications for Familial Hypercholesterolemia Diagnosis, Prognosis, and Family Screening
Raul D Santos
Atherosclerosis
|
June 23, 2009
Commentary on the study of Rivera et al.: The relation of risk factors and total coronary artery plaque burden evaluated by multi-detector row computed tomography angiography
Raul D Santos
Endocrine
|
March 28, 2012
Elevated uric acid, the metabolic syndrome and cardiovascular disease: cause, consequence, or just a not so innocent bystander?
Raul D Santos
Boletin Medico Del Hospital Infantil De Mexico
|
August 1, 1988
[Growth in children receiving a renal transplant]
D Santos-Atherton
Atherosclerosis
|
January 16, 2020
Absence of coronary artery calcification and low rates not only of coronary and cardiovascular mortality: Can the power of zero be expanded beyond the vessels?
Raul D Santos
Journal of Clinical Lipidology
|
September 19, 2020
From the President of the International Atherosclerosis Society
Raul D Santos
European Journal of Preventive Cardiology
|
February 21, 2021
EUROASPIRE V and uncontrolled risk factors in primary prevention: Atherosclerotic cardiovascular disease in the making
Raul D Santos
European Journal of Preventive Cardiology
|
February 21, 2019
Inadequate control of atherosclerotic cardiovascular disease risk factors in Europe: EUROASPIRE repeats itself
Raul D Santos
Page
of 153